Skip to main content
SOLENO THERAPEUTICS INC logo

SOLENO THERAPEUTICS INC — Investor Relations & Filings

Ticker · SLNO ISIN · US8342033094 LEI · 5493003LCY77N7FXK844 US Manufacturing
Filings indexed 1,059 across all filing types
Latest filing 2026-05-18 Regulatory Filings
Country US United States of America
Listing US SLNO

About SOLENO THERAPEUTICS INC

https://soleno.life/

Soleno Therapeutics, Inc. is a biopharmaceutical company focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. The company's lead product candidate is DCCR (Diazoxide Choline Controlled-Release), an investigational therapy for the treatment of Prader-Willi syndrome, a rare and complex genetic disorder. Soleno aims to address significant unmet medical needs for individuals living with life-threatening rare diseases.

Recent filings

Filing Released Lang Actions
S-8 POS
Regulatory Filings
2026-05-18 English
S-8 POS
Regulatory Filings
2026-05-18 English
S-8 POS
Regulatory Filings
2026-05-18 English
S-8 POS
Regulatory Filings
2026-05-18 English
S-8 POS
Regulatory Filings
2026-05-18 English
S-8 POS
Regulatory Filings
2026-05-18 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.